vialauditThe Roundup

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

VENDOR MATCHUP · AUDITED

Mile High Compounds vs Peptide Partners

Two audits, side by side. Composite, subscores, shipping, payment, coupons. Mile High Compounds takes the higher composite this cycle.

Composite score

HIGHER COMPOSITE
55
OF 100
VENDOR AUDIT

Mile High Compounds

53 Kovera records, no FAIL marks, 99.93% median purity; the 3 GLP products in FDA letter 721600 still sell under MHC code names. Public-data audit, 55/100.

vs
50
OF 100
VENDOR AUDIT

Peptide Partners

32 Kovera vial reports at a 99.83% median purity, three Kovera fails its own ledger omits, and open FDA warning letter 735063. Public-data audit, 50/100.

Subscore breakdown

7 METRICS
METRIC
MILE HIGH COMPOUNDS
PEPTIDE PARTNERS
Composite · weighted avg
55/100
vs
50/100
Purity / COA
70/100
vs
68/100
Shipping · domestic days
2.0d
vs
4.0d
Pricing
76/100
vs
78/100
Support
55/100
vs
45/100
Last tested
2026-10-09
vs
2026-10-09
Payment
card, ach
vs
card, wire

Catalog overlap

ONLY MILE HIGH COMPOUNDS
kpvnad-pluscagrilintide
BOTH
retatrutidetirzepatidesemaglutidebpc-157tb-500mots-css-31tesamorelinghk-cu
ONLY PEPTIDE PARTNERS
epitalon

Other matchups

ALL COMPARISONS →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH